Pertuzumab Combo Improved Invasive DFS in HER2-Positive Breast Cancer
The addition of pertuzumab to trastuzumab and chemotherapy improved invasive disease–free survival in patients with HER2-positive early breast cancer.
CAR T-Cell Therapy Effective in Multiple Myeloma
CAR T-cell therapy targeting B-cell maturation protein may be a new effective type of immunotherapy treatment for patients with multiple myeloma.
Dacomitinib Delayed Progression for NSCLC, Increased Adverse Events
Dacomitinib delayed progression of EGFR-positive non–small-cell lung cancer, but led to more adverse events compared with gefitinib.
Abiraterone/ADT Combo Increased Prostate Cancer Survival
Combined therapy with abiraterone acetate/prednisone plus ADT significantly improved overall survival and radiographic progression-free survival among men with metastatic hormone-naive prostate cancer.
STAMPEDE: Abiraterone Slowed Progression of Advanced Prostate Cancer
Abiraterone at the start of ADT for men with metastatic prostate cancer significantly improved overall survival and failure-free survival, with manageable toxicity.
Psychological Intervention Reduced Fear of Cancer Recurrence
Use of a psychological intervention—Conquer Fear—significantly reduced fear of cancer recurrence in cancer survivors in the first 6 months after treatment.
Brief Psych Intervention Reduced Distress Related to Advanced Cancer
A brief psychological intervention—Managing Cancer and Living Meaningfully (CALM)—significantly reduced distress in patients with advanced cancer.
Healthy Lifestyle Extended Survival After Colon Cancer Diagnosis
Patients with stage III colon cancer who maintained a healthy lifestyle had a reduced risk for death and a trend for a lower chance of recurrence.
Review Suggests FDA Should Tighten Regulations on Filtered Cigarettes
Evidence suggests that the inclusion of ventilation in cigarette filters has contributed to the increased rate of lung adenocarcinoma among smokers.
Single Surveillance Visit Reduced CRC Incidence in Adenoma Patients
Attending at least one surveillance visit with colonoscopy benefited most patients diagnosed with intermediate-risk adenomas, according to the results of a retrospective study.
By clicking Accept, you agree to become a member of the UBM Medica Community.